These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2575224)

  • 21. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD; Katz JL; Ricaurte GA
    Brain Res; 1992 Sep; 589(2):349-52. PubMed ID: 1382813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ecstasy--effects and toxicity. Distinct risks but uncertain long-term hazards].
    Series H; Lindefors N
    Lakartidningen; 1993 Aug; 90(32-33):2648-52. PubMed ID: 8103135
    [No Abstract]   [Full Text] [Related]  

  • 25. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.
    Logan BJ; Laverty R; Sanderson WD; Yee YB
    Eur J Pharmacol; 1988 Aug; 152(3):227-34. PubMed ID: 2906000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic investigation of compounds related to 3,4-methylenedioxyamphetamine (MDA).
    Davis WM; Borne RF
    Subst Alcohol Actions Misuse; 1984; 5(2):105-10. PubMed ID: 6147902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ["Ecstasy" and "ice": the return of the amphetamines].
    Kaminer Y; Zemishlany Z
    Harefuah; 1991 Jun; 120(12):727-9. PubMed ID: 1683637
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
    Scanzello CR; Hatzidimitriou G; Martello AL; Katz JL; Ricaurte GA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1484-91. PubMed ID: 7680719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk assessment for neurotoxic effects.
    Gaylor DW; Slikker W
    Neurotoxicology; 1990; 11(2):211-8. PubMed ID: 1700346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs.
    Schmidt CJ
    Eur J Pharmacol; 1987 Apr; 136(1):81-8. PubMed ID: 2885204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amphetamine analogs on neurotensin concentrations in rat brain.
    Merchant KM; Letter AA; Johnson M; Stone DM; Gibb JW; Hanson GR
    Eur J Pharmacol; 1987 Jun; 138(1):151-4. PubMed ID: 2887434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 34. Ion trap tandem mass spectrometric evidence for the metabolism of 3,4-(methylenedioxy)methamphetamine to the potent neurotoxins 2,4,5-trihydroxymethamphetamine and 2,4,5-trihydroxyamphetamine.
    Lim HK; Foltz RL
    Chem Res Toxicol; 1991; 4(6):626-32. PubMed ID: 1687259
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat.
    Frith CH; Chang LW; Lattin DL; Walls RC; Hamm J; Doblin R
    Fundam Appl Toxicol; 1987 Jul; 9(1):110-9. PubMed ID: 2887476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA.
    Steele TD; Brewster WK; Johnson MP; Nichols DE; Yim GK
    Pharmacol Biochem Behav; 1991 Feb; 38(2):345-51. PubMed ID: 1676172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,4-Methylenedioxymethamphetamine, serotonin and memory.
    Ricaurte GA; Markowska AL; Wenk GL; Hatzidimitriou G; Wlos J; Olton DS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1097-105. PubMed ID: 8102642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine.
    Noggle FT; DeRuiter J; Coker ST; Clark CR
    J Assoc Off Anal Chem; 1987; 70(6):981-6. PubMed ID: 3436914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurotoxic amphetamine analogues: effects in monkeys and implications for humans.
    Ricaurte GA; McCann UD
    Ann N Y Acad Sci; 1992 May; 648():371-82. PubMed ID: 1379014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.